Laddar...
Alemtuzumab in chronic lymphocytic leukemia
QUESTIONS: With respect to outcomes such as survival, response rate, response duration, time to progression, and quality of life, is alemtuzumab a beneficial treatment option for patients with B-cell chronic lymphocytic leukemia (cll)? What toxicities are associated with the use of alemtuzumab? Whic...
Sparad:
| Huvudupphovsmän: | , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Multimed Inc.
2007
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1899355/ https://ncbi.nlm.nih.gov/pubmed/17593982 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|